- Home
- GABC vs MIST Comparison
GABC vs MIST Comparison
Compare GABC & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GABC
- MIST
- Stock Information
- Founded
- GABC 1910
- MIST 2003
- Country
- GABC United States
- MIST Canada
- Employees
- GABC N/A
- MIST N/A
- Industry
- GABC Major Banks
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- GABC Finance
- MIST Health Care
- Exchange
- GABC Nasdaq
- MIST Nasdaq
- Market Cap
- GABC 1.4B
- MIST 53.9M
- IPO Year
- GABC N/A
- MIST N/A
- Fundamental
- Price
- GABC $38.74
- MIST $1.12
- Analyst Decision
- GABC Buy
- MIST Strong Buy
- Analyst Count
- GABC 4
- MIST 2
- Target Price
- GABC $44.50
- MIST $9.50
- AVG Volume (30 Days)
- GABC 105.2K
- MIST 1.6M
- Earning Date
- GABC 04-28-2025
- MIST 05-20-2025
- Dividend Yield
- GABC 2.96%
- MIST N/A
- EPS Growth
- GABC N/A
- MIST N/A
- EPS
- GABC 2.43
- MIST N/A
- Revenue
- GABC $256,672,000.00
- MIST N/A
- Revenue This Year
- GABC $42.82
- MIST N/A
- Revenue Next Year
- GABC $7.59
- MIST N/A
- P/E Ratio
- GABC $16.08
- MIST N/A
- Revenue Growth
- GABC 4.68
- MIST N/A
- 52 Week Low
- GABC $31.06
- MIST $0.63
- 52 Week High
- GABC $47.08
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- GABC 61.32
- MIST 46.48
- Support Level
- GABC $37.62
- MIST $1.28
- Resistance Level
- GABC $39.28
- MIST $1.32
- Average True Range (ATR)
- GABC 0.98
- MIST 0.12
- MACD
- GABC 0.30
- MIST 0.03
- Stochastic Oscillator
- GABC 86.79
- MIST 38.80
About GABC German American Bancorp Inc.
German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).